Cargando…

Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements

Vitamin A in high doses has been found to be highly teratogenic, leading to severe fetal abnormalities if exposure occurs during pregnancy. Hence, prescription vitamin A acne medications like isotretinoin are highly regulated via programs such as iPledge, which intend to avert fetal exposure to isot...

Descripción completa

Detalles Bibliográficos
Autores principales: Holla, Swathi, Zamil, Dina H, Paidisetty, Praneet S, Wang, Leonard K, Katta, Rajani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599455/
https://www.ncbi.nlm.nih.gov/pubmed/37885558
http://dx.doi.org/10.7759/cureus.45931
_version_ 1785125768420917248
author Holla, Swathi
Zamil, Dina H
Paidisetty, Praneet S
Wang, Leonard K
Katta, Rajani
author_facet Holla, Swathi
Zamil, Dina H
Paidisetty, Praneet S
Wang, Leonard K
Katta, Rajani
author_sort Holla, Swathi
collection PubMed
description Vitamin A in high doses has been found to be highly teratogenic, leading to severe fetal abnormalities if exposure occurs during pregnancy. Hence, prescription vitamin A acne medications like isotretinoin are highly regulated via programs such as iPledge, which intend to avert fetal exposure to isotretinoin and to educate healthcare providers, pharmacists, and patients about the significant risks associated with isotretinoin and its appropriate usage conditions. However, over-the-counter (OTC) vitamin A supplements are not subject to these requirements, and calculating the vitamin A content of these supplements can be difficult due to the lack of Food and Drug Administration (FDA) regulations and inconsistencies in labeling. If the necessary information is provided, ChatGPT, a generative artificial intelligence (AI) tool, can help the general public calculate the vitamin A content of supplements. Nonetheless, supplement manufacturers do not always provide the data necessary for these calculations.
format Online
Article
Text
id pubmed-10599455
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105994552023-10-26 Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements Holla, Swathi Zamil, Dina H Paidisetty, Praneet S Wang, Leonard K Katta, Rajani Cureus Public Health Vitamin A in high doses has been found to be highly teratogenic, leading to severe fetal abnormalities if exposure occurs during pregnancy. Hence, prescription vitamin A acne medications like isotretinoin are highly regulated via programs such as iPledge, which intend to avert fetal exposure to isotretinoin and to educate healthcare providers, pharmacists, and patients about the significant risks associated with isotretinoin and its appropriate usage conditions. However, over-the-counter (OTC) vitamin A supplements are not subject to these requirements, and calculating the vitamin A content of these supplements can be difficult due to the lack of Food and Drug Administration (FDA) regulations and inconsistencies in labeling. If the necessary information is provided, ChatGPT, a generative artificial intelligence (AI) tool, can help the general public calculate the vitamin A content of supplements. Nonetheless, supplement manufacturers do not always provide the data necessary for these calculations. Cureus 2023-09-25 /pmc/articles/PMC10599455/ /pubmed/37885558 http://dx.doi.org/10.7759/cureus.45931 Text en Copyright © 2023, Holla et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Public Health
Holla, Swathi
Zamil, Dina H
Paidisetty, Praneet S
Wang, Leonard K
Katta, Rajani
Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements
title Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements
title_full Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements
title_fullStr Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements
title_full_unstemmed Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements
title_short Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements
title_sort using artificial intelligence to assess the teratogenic risk of vitamin a supplements
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599455/
https://www.ncbi.nlm.nih.gov/pubmed/37885558
http://dx.doi.org/10.7759/cureus.45931
work_keys_str_mv AT hollaswathi usingartificialintelligencetoassesstheteratogenicriskofvitaminasupplements
AT zamildinah usingartificialintelligencetoassesstheteratogenicriskofvitaminasupplements
AT paidisettypraneets usingartificialintelligencetoassesstheteratogenicriskofvitaminasupplements
AT wangleonardk usingartificialintelligencetoassesstheteratogenicriskofvitaminasupplements
AT kattarajani usingartificialintelligencetoassesstheteratogenicriskofvitaminasupplements